Importantly, MM harboring inactivated TRAF3 and a hyperactivated NF-κB signature e.g. high expression of genes that are involved in NF-κB signaling, are associated to initial good response to proteasome inhibitors [24, 25]. Here, TRAF3 is linked to Miyoshi myopathy.